Perkins Capital Management »

NeoGenomics shares owned by Perkins Capital Management

Quarter-by-quarter ownership of NeoGenomics (NEO) shares owned by Perkins Capital Management from 13F filings

Historical chart of Perkins Capital Management investment in NeoGenomics

Tip: Access up to 7 years of quarterly data

All positions including NeoGenomics held by Perkins Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in NeoGenomics by Perkins Capital Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $925k 373k 2.48

More positions owned by Perkins Capital Management

Augmedix (AUGX)
Eli Lilly & Co. (LLY)
IDEXX Laboratories (IDXX)
Microsoft Corporation (MSFT)
Natera (NTRA)
Advanced Micro Devices (AMD)
Veracyte (VCYT)
Neogenomics Com New (NEO)
Quicklogic Corp Com New (QUIK)
Inuvo Com New (INUV)
Abbott Laboratories (ABT)
Alphatec Hldgs Com New (ATEC)
Axogen (AXGN)
Flexshopper Com New (FPAY)
LeMaitre Vascular (LMAT)

View all positions for Perkins Capital Management

Top funds holding NeoGenomics

Vanguard Group
Brown Advisory Holdings Incorporated
Henderson Group
Greenhouse Funds L
First Light Asset Management
Dimensional Fund Advisors
Goldman Sachs Group
Emerald Advisers
Fred Alger Management
Emerald Mutual Fund Advisers, Trust
Franklin Resources
Segall Bryant & Hamill
Bank of America Corporation
Charles Schwab Investment Management
Bank of New York Mellon

View all funds holding NeoGenomics